M[itotic]{.smallcaps} cell division is a process which ensures that a cell\'s chromosomes are faithfully replicated and equally segregated to two daughter cells. The kinetochore (centromere DNA and associated proteins) is essential to the high fidelity of chromosome transmission. The kinetochore mediates attachment of the chromosomes to the spindle microtubules (MTs)^1^ and directs chromosome movement during mitosis and meiosis (reviewed in [@B2]; [@B26]). The kinetochore--MT interaction is monitored by at least one centromere-based mitotic checkpoint system which delays onset of anaphase until stable bipolar attachment is achieved ([@B17]; [@B45]). Thus, kinetochores play both important structural and regulatory roles in ensuring faithful chromosome segregation during mitosis.

The kinetochores of *Saccharomyces cerevisiae* are relatively simple compared with the large trilaminar structures seen in multicellular eukaryotes ([@B43]; [@B41]). Major advances in defining components necessary for a functional kinetochore in yeast have implications for understanding the corresponding elements in more complex eukaryotes. The minimal functional centromere of *S*. *cerevisiae* (∼125 bp) is comprised of three conserved centromere DNA elements (CDEs). The central CDEII element consists of 78--86 bp of AT-rich DNA, and is flanked by two highly conserved palindromic motifs, CDEI (8 bp) and CDEIII (25 bp). Of these, CDEIII is absolutely essential for centromere function. In vivo, a unique nuclease resistant chromatin structure encompassing 160--220 bp is associated with *CEN* DNA and presumably corresponds to the yeast kinetochore ([@B3]; [@B12]). Seven genes that encode centromere proteins have been identified. Four of these, *NDC10/CTF14/CBF2* ([@B16]; [@B23]), *CEP3*/*CBF3* ([@B29]; [@B54]), *CTF13* ([@B7]), and *SKP1* ([@B6]; [@B51]) are essential for viability and encode the components of a multisubunit complex, CBF3, that binds to CDEIII DNA in vitro ([@B30]). *CBF1/CEP1/CPF1* encodes a nonessential basic helix-loop-helix protein which binds to CDEI ([@B1]; [@B5]; [@B36]). In addition, *MIF2*, a homologue of mammalian CENP-C, has been shown to interact with *CEN* DNA in a CDEIII- and CDEII-dependent manner ([@B37], [@B38]), and *CSE4*, a homologue of mammalian CENP-A, is suggested to be involved in a specialized centromeric nucleosome ([@B39]). Further analysis of the architecture of the CBF3 complex using DNA protein cross-linking ([@B8]) suggests that three subunits of CBF3, Ndc10p, Cep3p, and Ctf13p, are in direct contact with CDEIII over a region spanning 80 bp of DNA.

The binding of the CBF3 complex to CDEIII is necessary, but not sufficient for attachment of chromosomes to MTs. Several studies indicate the existence of other factors which are required to link the CBF3-DNA complex to polymerized MTs ([@B24]; [@B48]). The CBF3 subcomplex is thought to act as the nucleation site onto which these as yet unidentified components assemble and form active MT-binding complexes. A rich resource for identification of these additional kinetochore components is the chromosome transmission fidelity (*ctf*) mutant collection, which was isolated by the sole criterion of an increased rate of missegregation of a nonessential chromosome ([@B50]). Previously, two secondary in vivo genetic screens, the centromere transcriptional readthrough assay and the dicentric chromosome stabilization assay, were used to detect potential kinetochore mutants from this collection ([@B7]). A subset of 12 *ctf* mutants screened positive for the transcriptional readthrough assay. Three of these also tested positive for the dicentric stabilization assay. Two mutants were characterized in further detail, *ctf13-30* and *ctf14-42*, and were shown to correspond to *CTF13* and *CTF14* (*NDC10/CBF2*), genes which encode essential kinetochore proteins ([@B7]).

To identify other proteins involved in kinetochore structure or function, a third in vivo genetic assay was developed as a tertiary screen. This novel screen, which we have called synthetic dosage lethality (SDL; [@B28]), involves overexpressing a wild-type reference gene in a collection of target mutants. *CTF13*, encoding a known kinetochore protein ([@B7]), was used as the inducibly overexpressed reference gene to screen for synthetic interactions within a subset of 12 potential kinetochore *ctf* mutants. Overexpression of *CTF13* caused SDL in combination with four *ctf* mutants; one corresponded to a known kinetochore component, (*CTF14/NDC10*), and two were independent alleles of a previously uncharacterized gene, *CTF19*. We report here the cloning and detailed characterization of the *CTF19* gene. The genetic and biochemical results presented here indicate that Ctf19p represents a new kinetochore protein which may play a role as a molecular link between kinetochores and the mitotic spindle.

Materials and Methods {#MaterialsMethods}
=====================

Yeast Strains and Media
-----------------------

Table [I](#TI){ref-type="table"} lists the genotypes of all yeast strains used in this study. Media for yeast growth and sporulation were as described ([@B44]), except as otherwise indicated. For experiments monitoring the loss of a nonessential chromosome fragment, adenine was added to 6 μg/ml minimal media to enhance the development of the red pigment in *ade2-101* strains. For galactose inductions, strains were grown on solid medium containing 2% raffinose as the sole carbon source, and then transferred to solid medium containing 2% galactose, either with or without additional 2% raffinose. For experiments using liquid cultures, strains were grown in liquid medium containing 2% raffinose overnight, and galactose was added to a final concentration of 2% for the induction times indicated. To inhibit MT function in liquid cultures, nocodazole (NZ; Sigma Chemical Co.) was added to 20 μg/ml and cultures incubated at 25°C for 2 h, or to 15 μg/ml at 30°C for 90 min. To inhibit MT function on solid medium, benomyl (DuPont) was added at 5, 10, and 20 μg/ ml as indicated. DMSO alone was added to the media as a control. All yeast transformations were done by the method of [@B21].

Genetic Analysis
----------------

### Synthetic Lethality (SL) Studies.

Strains containing mutations in the gene of interest were mated to a *ctf19* null strain to create the heterozygous diploids. These strains were sporulated, dissected, and cultured at 25°C. At least two independent diploid clones were analyzed for each mating. To test for conditional interactions, all double mutant spores recovered at 25°C were assayed for growth at higher temperatures, initially at 30°C and 37°C. Other temperatures were tested if there was an indication of a conditional effect at a permissive temperature to determine the lowest temperature at which lethality was observed. All synthetic lethal interactions indicated by the tetrad data were confirmed by plasmid shuffle. CBF3 mutant strains which demonstrated potential SL with a *ctf19* null were mated to a *ctf19*Δ*1::TRP1* or *ctf19*Δ*1::HIS3* strain containing a wild-type copy of *CTF19* on a *URA3*-CEN plasmid (pKH7), sporulated and dissected. The *bub* (budding uninhibited by benzimidazole) and *mad* (mitotic arrest deficient) deletion strains were transformed with the appropriate wild-type gene (*BUB1*, *BUB2*, *BUB3*, or *MAD2*) on a *URA3*-CEN plasmid, mated back to the *ctf19* null strain, sporulated, and dissected. Double mutant spores recovered containing a *URA3*-marked plasmid were streaked on plates containing 5-FOA, which does not allow growth of cells expressing *URA3* ([@B4]). Therefore, only viable double mutants can grow on 5-FOA, and true synthetic lethals can not.

### SDL Studies.

Methods are as described previously ([@B28]). In brief, mutant strains were transformed under noninducing conditions, with overexpressing constructs containing either *CTF13* (pKF88) or *CTF19* (pKH21) reference genes under transcriptional control of a *GAL1* promoter, and the corresponding vector, p415GEU2. Expression of the reference gene was induced on solid medium containing 2% galactose. Growth was compared directly for each mutant containing either an overexpression plasmid or the respective vector alone. To test for conditional effects, transformants viable at 25°C were also assayed at 30°C and 37°C.

Molecular Cloning and Characterization of CTF19
-----------------------------------------------

The chromosome missegregation phenotype of *ctf19-58* was confirmed to be due to a single genetic mutation through genetic analysis after backcrossing this mutant strain to its wild-type parent (YPH277). The *CTF19* gene was cloned by complementation of the *ctf* sectoring phenotype from a library containing 10--12-kb fragments of yeast genomic DNA inserted into a *LEU2*-CEN vector (Spencer, F., and P. Hieter, unpublished results). Appropriate restriction fragments were used for subcloning the genomic DNA into pRS based vectors ([@B46]). A 2-kb MluI-NsiI fragment rescued the sectoring phenotype and was shown to contain the *CTF19* gene by genetic linkage analysis. *CTF19* was physically mapped to chromosome XVI by hybridization of a \[^32^P\] labeled SalI-NsiI fragment to filters containing overlapping lambda and cosmid clones of the *S*. *cerevisiae* genome ([@B32]). This placed *CTF19* on the right arm of chromosome XVI, 40--50 kb from *CEN6*, distal to *RAD1*.

A complete deletion of the *CTF19* open reading frame (ORF) was generated using PCR-mediated gene disruption ([@B33]). Oligonucleotides for PCR were synthesized as follows. OKH1 (5′-GTGTGATCTTGTT GATAC TAGGT CGCAAAGAACGCAAATAGATTG- TACTGAGAGTGCAC-3′) has a 40-bp homology to the sense strand upstream of the *CTF19* ATG, followed by a 20-bp sequence from the plus strand of pRS vectors ([@B46]) adjacent to the vector selectable marker. OKH2 (5′-GTTTAAGCAAGCCGTCCAGTTGGCAATGGCAAATGGAACACTGTGCGGTATTTCACACCG-3′) has a 40-bp homology to the antisense strand downstream of the stop codon followed by a 20-bp sequence from the minus strand of pRS vectors adjacent to the vector selectable marker. OKH1 and OKH2 can be used to incorporate any one of the markers from the pRS vectors (*URA3*, *HIS3*, *LEU2*, or *TRP1*) by PCR. These oligonucleotides were used to amplify either *HIS3* from pRS303 or *TRP1* from pRS304. The *HIS3* PCR product was transformed into the haploid strain YPH877 and the diploid strain YJP57. The *TRP1* PCR product was transformed in the haploid strain YPH1125 and the diploid strain YPH982 (Table [I](#TI){ref-type="table"}). Gene replacement was confirmed in each case by Southern blot analysis.

Plasmids and Epitope-tagged Constructs
--------------------------------------

Plasmids containing *CTF19* fused to the *GAL1* promoter, either with or without an in frame E1 epitope tag, were constructed from the plasmid p415GEU1 and p415GEU2, respectively ([@B6]; [@B28]). A PCR strategy was used to place the second codon of *CTF19* in frame with the ATG of p415GEU1 and p415GEU2, using a 5′ engineered Xho1 cloning site and a downstream engineered HindIII site (Fig. [1](#F1){ref-type="fig"} b). To avoid possible PCR errors, a wild-type PstI (bp 566 in ORF) HindIII (in multiple cloning site) genomic fragment was used to replace the 3′ end of the PCR-generated sequence in pKH20. When transformed into a *ctf19* deletion strain containing pKF88 (*CTF13* overexpression construct; [@B28]), both pKH20 and pKH21 were able to rescue the SDL phenotype. pKH20 and pKH21 were also able to stabilize a chromosome fragment in the *ctf19* deletion strain when compared with the vector alone control on galactose containing media.

To make an HA epitope-tagged construct, a PCR based site-directed mutagenesis method which utilizes Pfu polymerase was used to engineer a StuI site directly 3′ to the ATG of *CTF19* in pKH6 (protocol from QuickChange™ site-directed mutagenesis kit; Stratagene), creating pKH27. Three tandem copies of the 9--amino acid HA epitope tag ([@B10]) were amplified by PCR from the vector pSM492 (a gift from Susan Michaelis) with StuI sites engineered on the 5′ and 3′ ends. The triple HA tag was ligated into the StuI site engineered at the NH~2~ terminus of *CTF19*, and this epitope-tagged fusion construct was subcloned into pRS313 and pRS315, generating pKH31 and pKH32, respectively (Fig. [1](#F1){ref-type="fig"} c). These constructs were transformed into *ctf19*Δ*1::TRP1* (YPH1319) and shown to rescue the chromosome missegregation phenotype. The *CTF19-3HA* fusion was integrated into the genome by gamma integration ([@B46]). A 1.4-kb XhoI-SmaI fragment containing *CTF19-3HA* from pKH32 was subcloned into a *HIS3* marked gamma integration vector, p679 ([@B7]), which is designed to direct an integration event at the *leu2*Δ*1* locus on chromosome III. The resulting integrating construct, pKH35, was linearized at the NotI site, between the targeting sequences to the left (5′) and right (3′) of the *leu2*Δ*1* locus, and transformed into a *ctf19*Δ*1::TRP1* deletion strain (YPH1317), creating *leu2*Δ*1::CTF19-HA3* (YPH1327). Integration at the *leu2*Δ*1* locus was confirmed by colony PCR analysis, using primers OMB-*leu2*Δ (5′-GTGTAGAATTGCAGATTCCC-3′, provided by M. Basrai) and T7. An integration event targeted correctly to the genomic *leu2*Δ*1* locus results in a 550-bp product. Both the plasmid based and genome integrated versions of the *CTF19-3HA* epitope-tagged fusion produce the same 48-kD band by Western blotting and probing with anti-HA antibody, which is not seen in control strains containing a wild-type untagged copy of *CTF19*.

Quantitation of Chromosome Missegregation
-----------------------------------------

Colony color half sector analysis was performed as previously described ([@B27]; [@B14]). In brief, homozygous diploid strains (YPH982, *CTF19/CTF19*; YPH1320, *ctf19*Δ*::TRP1/ctf19*Δ*:: TRP1*; YPH1321, *ctf19-58/ctf19-58*; and YPH1322, *ctf19-26/ctf19-26*) containing a single *SUP11-*marked chromosome fragment were plated to single colonies on solid media containing a limiting amount of adenine (6 μg/ml), and grown at 30°C. The red pigment was allowed to develop at 4°C before scoring the sectoring phenotypes. Colonies scored as half-sectored were ≥50% red. A 1:0 missegregation event (chromosome loss) in the first division results in pink/red half-sectored colonies, whereas a 2:0 missegregation event (nondisjunction; chromosome gain) results in white/ red half-sectored colonies.

Flow Cytometry and Cytological Analysis
---------------------------------------

Cells were processed for flow cytometry as previously described ([@B14]), with a few modifications. In brief, logarithmically growing cells were pelleted, resuspended in 0.2 M Tris, pH 7.5, containing 70% ethanol, and fixed overnight at 4°C. Cells were treated with 1 mg/ml RNase A at 37°C for 1 h. Proteinase K was added, and the cell suspension incubated at 55°C for 1 h. Cells were stained overnight at 4°C in 0.2 M Tris containing 3 μg/ml propidium iodide (Sigma Chemical Co.). Before being subjected to flow cytometry, cells were sonicated, using a Branson sonifier 450 on a setting of two for 2--5 s. Aliquots of cells fixed with 3.7% formaldehyde, as described for immunofluorescence, were stained with 300 ng/ml 4′,6-diamidino-2-phenylindole (DAPI) to analyze nuclear morphology, and anti--α-tubulin decorated with fluorescein isocyanate, to analyze spindle morphology.

For experiments comparing *ctf13-30* and *ctf19*Δ*1* single mutants to *ctf13-30 ctf19*Δ*1* double mutants, cultures of wild-type (YPH501), *ctf13-30/ctf13-30* (YPH1329), *ctf19*Δ*1::HIS3*/*ctf19*Δ*1::HIS3* (YPH1330), and *ctf19*Δ*1::HIS3*/*ctf19*Δ*1::HIS3 ctf13-30*/*ctf13-30* (YPH1331, YPH1332) were grown at 25°C to early log stage (∼10^6^ cells/ml), then split at time = 0, keeping half of the culture at 25°C and shifting the other half to 37°C. Samples were taken at the start of the experiment (time = 0), and at 3 and 5 h after the temperature shift. For each time point, samples were assayed for viability, nuclear and spindle morphology, and cell DNA content by flow cytometry.

Isolation of Minichromosomes and MT-Binding Assay for Yeast Centromeres
-----------------------------------------------------------------------

Isolation of minichromosomes from yeast cells and assaying their ability to bind to MTs were performed as previously described ([@B24]).

In Vivo Cross-Linking and Chromatin Immunoprecipitation
-------------------------------------------------------

The methods used for chromatin immunoprecipitation and the PCR primers used to amplify both centromeric and noncentromeric test loci were as described in [@B38]. Purified HA mAb 12CA5 (Berkeley Antibody Co.) was added at either a 1:250 dilution (resulting in a 4 μg/ml final concentration), or 50 μl of HA antibody pre--cross-linked to CNBr--Sepharose beads was added to the chromatin solution. Crude anti-Mif2p rabbit antisera, provided by Pam Meluh (Carnegie Institute of Washington, Baltimore, MD), was used at a 1:250 dilution and served as a positive control for this assay. For NZ treatment experiments, NZ was added to logarithmically growing cells at 15 or 20 μg/ml final concentration, and incubated for 90 min at 30°C to completely depolymerize MTs before fixation.

Immunofluorescence
------------------

Ctf19p was localized by indirect immunofluorescence microscopy as described by [@B42], with a few modifications. To visualize MTs, cells were fixed with 3.7% formaldehyde for 90 min at 30°C. To visualize Ctf19-HAp or Tub4p, cells were fixed for 60 min at 25°C. Primary antibodies were diluted in block solution (4% milk, 2% BSA, and 0.1% Tween in 1× PBS) as follows: 1:50 for anti--α-tubulin (YOL1/34, Serra Lab), 1:5,000 for anti-HA antibody (12CA5, Boehringer Mannheim Corp.), and 1:500 for anti-Tub4p (provided by L. Marschall; see [@B35]). Affinity-purified secondary antibodies (Cappel Research Products) were used at 1:1,000 dilution in block solution. YOL1/34 was detected with rhodamine conjugated goat anti--rat antibodies, anti-HA antibody was detected with fluorescein conjugated goat anti--mouse antibodies, and anti-Tub4p was detected with CY3 conjugated goat anti--rabbit antibodies (Jackson ImmunoResearch Laboratories, Inc.). When costaining for Ctf19-HAp and either α-tubulin or Tub4p, primary and secondary antibodies were applied in rounds, with anti-HA and goat anti--mouse applied first, to avoid background from secondary antibody cross-reactivity. Cells were examined using fluorescence microscopy with a Zeiss Axioskop fitted with UV, fluorescein isothiocyanate, and rhodamine/CY3 optics and a 100× objective. Digital images were captured using a cooled charged-coupled device (CCD) camera (Photometrix) and IPLabSpectrum software (Signal Analytics).

Results {#Results}
=======

Isolation and Characterization of the CTF19 Gene
------------------------------------------------

An SDL screen ([@B28]) was performed in which *CTF13* was inducibly overexpressed in a subset of 12 potential kinetochore *ctf* mutants, which tested positive for the centromere transcription readthrough assay ([@B7]). Overexpression of *CTF13* caused SDL in combination with four mutants within this set: *ndc10-42*, *ctf17-61*, *ctf19-26 (YCTF26)*, and *ctf19-58 (YCTF58)*. The chromosome missegregation *ctf* phenotype (visualized by the formation of red sectors in a white colony) of *ctf19-58* was confirmed by genetic analysis to be due to a single nuclear mutation, and the corresponding gene was cloned by complementation of this phenotype (see Materials and Methods; Fig. [1](#F1){ref-type="fig"} a). *CTF19* was localized to the right arm of chromosome XVI using physical mapping methods. Nucleotide sequencing of the 2-kb *CTF19* clone revealed a previously unidentified 1.2-kb ORF that encodes a protein of 369 amino acids with a predicted molecular mass of 40 kD. Database searching revealed no significant overall homology at the amino acid level. Protein motif searching (ProSite) revealed a putative leucine zipper beginning at amino acid 131 (Fig. [1](#F1){ref-type="fig"} d). The sequence and mapping data of *CTF19* (YPL018W) was corroborated upon release of the complete sequence of the *S*. *cerevisiae* genome ([@B15]).

*ctf19-26* was confirmed to be an independent allele of *CTF19* using four lines of evidence: first, the cloned *CTF19* DNA complements the *ctf19-26* sectoring phenotype; second, the *ctf19-58*/*ctf19-26* diploid exhibits a chromosome missegregation phenotype; third, when this diploid is sporulated, all spores which bear a chromosome fragment display the sectoring phenotype (Basrai, M., personal communication); and fourth, when *ctf19-26* is crossed to a wild-type strain with the *LEU2*-marked genomic *CTF19* locus (YPH1313), the *ctf* phenotype always segregated away from the *LEU2* marker.

A complete deletion of the *CTF19* ORF was generated using PCR-mediated gene disruption ([@B33]). The *CTF19* ORF was replaced with two different marker genes, creating *ctf19*Δ*1::HIS3* and *ctf19*Δ*1::TRP1*. The deletion strains are viable, display no temperature conditional phenotypes, and exhibit a chromosome missegregation phenotype similar to that seen in strains containing either of the original mutant alleles, *ctf19-58* or *ctf19-26*. Upon overexpression of *CTF13* under the control of a *GAL1* promoter, SDL was observed in the deletion strain, comparable to that seen with *ctf19-58* and *ctf19-26*, albeit somewhat more pronounced.

ctf19 Mutants Display Phenotypes Consistent with a Role in Kinetochore Function
-------------------------------------------------------------------------------

Strains carrying the *ctf19*Δ*1*, *ctf19-58*, or *ctf19-26* mutations were tested for sensitivity to benzimidazole compounds. These agents cause depolymerization of MTs, and it has been observed that kinetochore mutants, as well as mitotic checkpoint mutants, are sensitive to compounds such as benomyl ([@B50]; [@B20]; [@B31]). All three strains are highly sensitive to 10 μg/ml of benomyl at 25°C, and slightly sensitive at the level of 5 μg/ml (Fig. [2](#F2){ref-type="fig"} a). Isogenic wild-type strains grow well with 10 μg/ml of benomyl at 25°C, and are sensitive to 20 μg/ml. As an interpretive note, the *bub* ([@B20]) and *mad* ([@B31]; [@B19]) mutants are also sensitive to 10 μg/ml of benomyl.

Examination of possible cell cycle defects revealed that a *ctf19*Δ*1/ctf19*Δ*1* mutant shows a G2/M accumulation with 2C DNA content in a logarithmically growing culture (Fig. [2](#F2){ref-type="fig"} b). Cytological analysis of these cells reveals an accumulation of large budded cells with the nucleus at or near the neck (29% in *ctf19*Δ*1* versus 6% in wild-type). A similar G2 delay is seen in *ctf13-30*, *ndc10-42* ([@B7]), *cep3-1/-2* ([@B54]), and *skp1-4* ([@B6]) kinetochore structural mutants at their nonpermissive temperatures. While there is an accumulation of large budded uninucleate cells, the number of telophase cells in the *ctf19* null mutant remains similar to that seen for wild-type, 17% versus 16%, respectively. In contrast, the percentage of telophase cells in a *ctf13-30* mutant at the nonpermissive temperature drops to 3%. This is consistent with the notion that *ctf13-30* cells experience a strong arrest at G2/M at the nonpermissive temperature, whereas *ctf19* null cells experience a shorter delay, most likely because the lesion is less severe.

Chromosome missegregation in the *ctf19* mutants was quantitated in homozygous diploid strains using colony color half sector analysis ([@B27]). Chromosome loss (1:0 segregation) results in a pink/red half-sectored colony, whereas nondisjunction (2:0 segregation) results in a white/red half-sectored colony. The rate of chromosome loss in a *ctf19*Δ*1/ctf19*Δ*1* mutant is ∼100 times greater than that of wild-type, and the rate of nondisjunction is 60-fold higher than wild-type (Table [II](#TII){ref-type="table"}). For *ctf19* mutant alleles, the rates of chromosome loss and nondisjunction are 77- and 17-fold higher than wild-type for *ctf19-58*/*ctf19-58*, and 37- and 13-fold higher for *ctf19-26/ctf19-26,* respectively. Thus, both chromosome loss and gain are occurring in *ctf19* mutant diploids, and the deletion strain is affected the most severely. Similar rates of chromosome loss and nondisjunction have been reported for essential kinetochore mutants *ctf13-30* ([@B7]) and *skp1-4* ([@B6]).

Ctf19p Interacts Genetically with Components of the Kinetochore and the Mitotic Spindle Checkpoint
--------------------------------------------------------------------------------------------------

To explore a potential role of Ctf19p in kinetochore function, genetic analysis was used to look for synthetic phenotypes between *ctf19* mutants and known kinetochore mutants. As our first genetic test, we used the SDL screen ([@B28]) to assay the effect of overexpression of *CTF19* in a wild-type background, and in strains containing mutations in each of the four subunits of the CBF3 kinetochore complex. *CTF19*, the reference gene, was placed under a *GAL1* promoter (pKH21, Fig. [1](#F1){ref-type="fig"} b) and this plasmid was transformed into a set of target mutants (*ndc10*, *cep3*, *ctf13*, and *skp1*). Growth was assessed upon galactose induction, as previously described ([@B28]). Results of this dosage study are summarized in Table [III](#TIII){ref-type="table"}. SDL was seen when *CTF19* was overexpressed in the background of two independent mutant alleles of *NDC10*, *ndc10-42*, and *ndc10-1*, thus providing another genetic link between *CTF19* and the kinetochore. Moreover, overexpression of *NDC10* results in lethality in *ctf19-26* and *ctf19-58* mutants. The plasmid expressing *CTF13* under a *GAL1* promoter (pKF88) was also transformed into these mutant strains and viability assessed. Overexpression of *CTF13* results in SDL in *ndc10-42* (as previously described), and also in *ndc10-1* at elevated temperature (30°C), as well as *cep3-1* and *cep3-2* (Table [III](#TIII){ref-type="table"}).

To look for additional genetic interactions between *CTF19* and CBF3 kinetochore mutations, double mutants were made between a *ctf19* null mutant and the same CBF3 subunit mutations used in the dosage studies above. The heterozygous diploids were sporulated at 25°C and tetrads analyzed (Table [IV](#TIV){ref-type="table"}). To detect any conditional interactions, all double mutants recovered at 25°C were assayed for growth at successively higher semipermissive temperatures. The *ctf19*Δ*1 ctf13-30* double mutant showed conditional SL at 30°C, which is lower than the nonpermissive temperature of *ctf13-30* alone (35.5°C; [@B7]). *ctf19*Δ*1 ndc10-42* double mutants could not be recovered at 25°C, although *ctf19*Δ*1 ndc10-1* double mutants were viable at all permissive temperatures tested, demonstrating allele specific SL. *ctf19*Δ*1 skp1-4* double mutants were conditionally synthetic lethal at 28°C, whereas *ctf19*Δ*1 skp1-3* double mutants were viable at all permissive temperatures. This allele specificity is significant since the *skp1-4* allele arrests in G2, and the *skp1-3* allele arrests in G1 at the respective nonpermissive temperatures ([@B6]), suggesting that the interaction detected between *CTF19* and *SKP1* is within the G2/M phase of the cell cycle. Similarly, a conditional synthetic lethal interaction was detected between *ctf19*Δ*1* and *sgt1-3*, but not with *sgt1-5* (*SGT1* is a suppressor of *skp1-4*; Kitagawa, K., personal communication). *sgt1-3* arrests at G2/M, whereas *sgt1-5* arrests at G1/S. Therefore, this allele specificity is analogous to the *ctf19*Δ*1-skp1-4* interaction. Finally, both mutant alleles of *CEP3* tested, *cep3-1* and *cep3-2*, were synthetically lethal with *ctf19*Δ*1* at 25°C. Thus, *CTF19* genetically interacts with all four components of the CBF3 CDEIII-binding complex.

To address the specificity of these genetic interactions, a *ctf19*Δ*1* strain was crossed to strains containing *cbf1:: TRP1*, *cse4-1*, or *mif2-3* mutations, representing other proteins which function at the kinetochore, as well as *tub1-1* or *tub2* tubulin mutations. No synthetic lethal interactions were detected in any of the corresponding double mutants, except for *ctf19*Δ*1 mif2-3*, which is inviable (Table [IV](#TIV){ref-type="table"}). Interestingly, [@B38] have shown that Mif2p interacts with *CEN* DNA primarily through CDEIII. Thus, the genetic interactions identified between *CTF19* and the kinetochore appear specific for CBF3 and other CDEIII-associated components.

The *ctf19*Δ*1 ctf13-30* double mutant was a valuable reagent, because double mutants could be recovered at 25°C, but were conditionally synthetic lethal at 30°C. It has been shown that *ctf13-30* alone causes initiation of the mitotic checkpoint at the nonpermissive temperature, resulting in delay at the G2/M point of the cell cycle ([@B7]). When *ctf13-30* is combined with *mad2* or *bub1* mitotic checkpoint mutants, the cells do not arrest upon shift to the nonpermissive temperature, and rapid death ensues ([@B56]; [@B40]). In contrast, when *ctf13-30* is combined with a *ctf19*Δ*1* mutant, although a rapid loss in viability is observed upon shift to the nonpermissive temperature, the checkpoint appears to be intact judging by a G2/M delay visible in flow cytometry profiles at 25°C and 37°C (data not shown). This G2/M delay in the double mutant is accompanied by an accumulation of large budded uninucleate cells with short spindles. The inability of the *ctf19*Δ*1 ctf13-30* double mutant to recover after exposure to the nonpermissive temperature suggests that there is a more severe structural aberration than in the *ctf13-30* mutant alone.

In light of the observations that the mitotic spindle checkpoint responds to impaired kinetochore function ([@B56]; [@B40]; [@B58]), we asked directly whether *CTF19* genetically interacts with *BUB1*, *BUB2*, *BUB3*, or *MAD2* mitotic checkpoint genes. To do this, we again used the SDL assay. The *CTF19* overexpression plasmid (pKH21) was transformed into mitotic checkpoint target mutants, *bub1*Δ, *bub2*Δ, *bub3*Δ, and *mad2*Δ. Upon induction of *CTF19* on galactose-containing medium, growth was assessed as previously described. SDL was observed in the *bub1*Δ and *bub3*Δ strains, but no defect of growth was seen with *mad2*Δ or *bub2*Δ. To interpret these results, we also determined the effect of overexpressing *CTF13* in the same target mutants, especially since the *ctf13-30* mutation triggers the mitotic checkpoint resulting in a G2/M delay, as described above. When *CTF13* was overexpressed in combination with *bub2*Δ, *bub3*Δ, and *mad2*Δ, SDL was observed with *bub3*Δ, but not with *mad2*Δ or *bub2*Δ.

To test for synthetic lethal interactions, crosses were made between strains carrying a *ctf19* null mutation and strains carrying either *bub1*Δ, *bub2*Δ, *bub3*Δ, or *mad2*Δ mutations (Table [V](#TV){ref-type="table"}). A *rad9*Δ mutation, previously characterized as defective in monitoring incomplete replication and DNA damage ([@B57]; [@B34]), was also tested. SL was seen when *ctf19*Δ*1* was combined with *bub1*Δ, *bub3*Δ, or *mad2*Δ, but not with *bub2*Δ or *rad9*Δ (Table [V](#TV){ref-type="table"}). Bub1p, Bub3p, and Mad2p are all necessary for the initiation of the mitotic checkpoint pathway and are sufficient for shorter delays, as seen with low levels of NZ, whereas Bub2p is required for maintaining longer delays, as seen with high levels of NZ ([@B56]; [@B40]). These synthetic dosage lethal and synthetic lethal genetic interaction results are consistent with the notion that *ctf19* mutations invoke a mild premitotic delay, which does not require Bub2p. Taken together, these genetic studies strongly suggest that Ctf19p plays a structural role at the kinetochore.

Ctf19p Interacts with Centromere DNA In Vivo
--------------------------------------------

Sucrose gradient sedimentation analysis revealed that Ctf19-HAp sediments with an S value of 20 (data not shown). This suggests that Ctf19p may be part of a large protein complex in the cell. There is no evidence that Ctf19p is part of the CBF3 CDEIII-binding complex, as Ctf19p is not required for the normal *CEN* DNA bandshift in vitro, and antibodies to an epitope-tagged Ctf19p do not result in a supershift of the CBF3-*CEN* DNA complex (data not shown; [@B52]). In addition, coimmunoprecipitation experiments using crude yeast cell extracts were unable to detect a direct interaction between Ctf19p and CBF3 proteins.

Knowing that Ctf19p is not a part of the CDEIII-binding complex detected by *CEN* DNA bandshift in vitro, we investigated other ways in which it could be involved in kinetochore function. One possibility is that Ctf19p plays a role in binding of MTs to kinetochores. To test this hypothesis, an in vitro assay was used which measures the ability of yeast centromeres to bind to MTs ([@B24]). In this assay, minichromosomes containing a centromere are introduced into wild-type or mutant strains, and purified chromatin is prepared. Taxol-stabilized bovine MTs are added to the lysate and sedimented. The supernatant and pellet are separated, DNA from each fraction is extracted, and the relative amount of the minichromosome in each fraction is determined. In wild-type cultures with wild-type centromeres on the minichromosomes, the minichromosomes sediment with the MTs. *CEN* DNA mutations in CDEII and CDEIII abolish the centromere\'s ability to bind MTs ([@B24]). Similarly, trans-acting mutations in *CEN*-binding proteins also inhibit the ability of the minichromosome to bind MTs, exemplified by the *cep3-1* mutant ([@B54]). Two independent alleles of *CTF19* were tested in this assay, *ctf19-58* and *ctf19-26*, and both were shown to exhibit a dramatic defect in centromere-dependent binding of minichromosomes to MTs (Fig. [3](#F3){ref-type="fig"}). Therefore, knowing that Ctf19p interacts genetically with the CBF3 complex, is important for binding MTs to centromeres of minichromosomes, and sediments with an S value consistent with being part of a protein complex, we next investigated whether Ctf19p is involved in a higher order centromere complex.

To examine whether Ctf19p physically interacts with a kinetochore macromolecular complex, we used an in vivo cross-linking and immunoprecipitation strategy ([@B38]). Formaldehyde cross-linked chromatin (2 h fixation) prepared from an epitope-tagged *CTF19-3HA* strain and a wild-type untagged control strain were sonicated to shear the DNA and immunoprecipitated with anti-HA antibody. After reversing the cross-links, the presence of specific DNA sequences in the immunoprecipitates was assessed by PCR analysis. Mif2p, which was previously shown to associate with *CEN* DNA in vivo ([@B38]), served as a positive control for this assay. Two *CEN* DNA sequences were tested, *CEN3* and *CEN16*, and both were found to be present in the Ctf19-HAp immunoprecipitate, but not in the untagged control strain or in the mock-treated control (Fig. [4](#F4){ref-type="fig"} a). The anti-Mif2p immunoprecipitate also contained these *CEN* DNA sequences. To test if the interaction detected is specific for *CEN* DNA, two noncentromeric loci, *PGK1* and *HMRa*, which are AT-rich intergenic regions located on yeast chromosome III, were analyzed. Both of these sequences were not found in the Ctf19-HAp immunoprecipitate, as was the case with the Mif2p positive control (Fig. [4](#F4){ref-type="fig"} a). Thus, as predicted by the numerous genetic interactions with kinetochore protein components, Ctf19p specifically associates with the centromere in chromatin preparations.

It is plausible that the association of Ctf19p with the centromere is transient and contact may be made with kinetochore proteins upon MT attachment. To test whether MTs are necessary for Ctf19p to associate with the centromere, the chromatin immunoprecipitation assay was performed with strains grown in the presence of NZ, a MT depolymerizing agent. Results from this experiment show that, as with Mif2p and Ndc10p (not shown), Ctf19p specifically immunoprecipitates *CEN* DNA, and not noncentromeric loci, even in the presence of NZ (Fig. [4](#F4){ref-type="fig"} b). These data further support the conclusion that Ctf19p is in fact part of a centromere--protein complex.

Ctf19p Localizes Near the Spindle Pole Body (SPB)
-------------------------------------------------

The localization of Ctf19p in yeast cells was determined by indirect immunofluorescence using an HA epitope fusion construct (pKH32). To avoid potential copy number effects, the *CTF19-3HA* fusion was integrated into the genome at the *leu2*Δ*1* locus (*leu2*Δ*1::CTF19-3HA*, YPH1327). For immunofluorescence studies, an asynchronous population of cells from strains containing *CTF19-3HA* (either plasmid-based or integrated, YPH1324 or YPH1327) or an untagged control (YPH1323 or YPH500) were formaldehyde-fixed, and stained with anti-HA antibody and anti--α-tubulin, which stains spindle MTs. The HA antibody detected a bright dot at the vertex of the MTs in interphase cells, and at the ends of the spindle in mitotic cells (Fig. [5](#F5){ref-type="fig"}). This staining pattern, reminiscent of SPB staining, is similar to that seen with other centromere proteins, including Ndc10p ([@B16]), Mif2p ([@B38]), and Cse4p ([@B39]), and is consistent with the notion that centromeres display a nonrandom localization throughout the cell cycle, clustering near the SPB during interphase (G1) and late mitosis (anaphase and telophase; [@B18]; [@B53]). A key difference between the staining pattern observed for Ctf19-HAp and those reported for other centromere proteins occurs during early mitosis. Both Ndc10p and Cse4p are reported to stain the spindle MTs, evident as a short bar, in cells with short spindles. Ctf19-HAp staining, however, resolves into two distinct foci even in cells with short spindles.

To examine the specificity of this localization, we obtained antibodies against Tub4p (provided by L. Marschall, Stanford, CA), which served as an SPB marker ([@B47]; [@B35]; [@B49]). Tub4p, the γ-tubulin homologue in *S*. *cerevisiae*, is part of a complex that localizes to the inner and outer plaques of the SPB ([@B13]; [@B25]), where nuclear and cytoplasmic MTs are organized, respectively. Costaining experiments revealed that Ctf19-HAp localizes to the same region as Tub4p (Fig. [6](#F6){ref-type="fig"}, a and b). Further analysis of cells stained for both Ctf19-HAp and Tub4p revealed that the Ctf19-HAp signal appears to be just interior to (on the nucleoplasmic side of) the Tub4p signal in mid-mitotic cells with short spindles (Fig. [6](#F6){ref-type="fig"} d). This observation was examined in more detail by measuring the distance between the Ctf19-HAp signals and Tub4p signals in individual cells. The average distance between Ctf19-HAp signals for 50 mitotic cells was 1.5 μm ± 1.1, whereas the comparable distance between Tub4p signals was 1.8 μm ± 1.1. These measurements correspond to an average distance of 0.2 μm between Ctf19p and Tub4p in mitotic cells. To interpret the significance of this difference, it should be considered that Tub4p resides on both nuclear and cytoplasmic surfaces of the SPB and that the fluorescent signal observed for Tub4p is an average of both signals. Therefore, the distance from the Ctf19-HAp signal to the nuclear side of the SPB may be less than indicated by these measurements. These data suggest that Ctf19p localizes near the SPB, but, as expected, is not likely to be an integral component of the SPB. Consistent with this hypothesis, we were unable to demonstrate a direct interaction between Ctf19-HAp and Tub4p by coimmunoprecipitation (data not shown). It is possible that Ctf19p is part of a complex which resides at the nucleoplasmic surface of the SPB and transiently interacts with kinetochores. However, it is more likely that the staining pattern observed for Ctf19-HAp corresponds to a centromere localization, as noted above for other kinetochore proteins, and is thus compatible with data implicating a kinetochore function for Ctf19p.

To test if we could differentiate between these two hypotheses, we asked whether Ctf19p requires MTs for its localization. Assuming that kinetochores are tethered to the SPB in a MT-dependent manner ([@B18]), cells were treated with 15 μg/ml NZ (a concentration that depolymerizes all MTs) and examined by immunofluorescence. For proteins that are known to be integral components of the SPB, localization is unchanged by the presence of NZ ([@B35]). Fluorescent in situ hybridization analysis has revealed that centromere localization is, however, changed in the presence of NZ as they are no longer clustered ([@B18]). It should be noted that, although NZ and other benzimidazole drugs depolymerize most of the MTs, it is possible that a small amount of the polymer which is undetectable by immunofluorescence remains ([@B35]; [@B22]). Interestingly, Ctf19p localization in most cells remained near the SPB, visualized as one (∼66% of cells) or two (∼27% of cells) brightly staining dots (Fig. [6](#F6){ref-type="fig"} c). This compares to 69% and 31%, respectively, in cells not treated with NZ. However, ∼7% of the cells (out of 500 cells analyzed) contained three or four discrete signals for Ctf19-HAp. There were also cells observed in which two signals were seen for Ctf19-HAp, but only one signal was seen for Tub4p. These observations indicate that the majority of Ctf19p remains near the SPB in the absence of MTs, however, a portion of the protein in some cells has an altered localization in the presence of NZ. These results may indicate that Ctf19p is present both at the centromere and near the nucleoplasmic surface of the SPB. Whether or not these localization data are suggestive of a function for Ctf19p at the SPB, or merely a consequence of the limitations of the assay, has yet to be determined.

CTF19 Interacts Genetically with a Spindle- and Pole-associated Protein
-----------------------------------------------------------------------

As a preliminary investigation into a potential role for Ctf19p at the SPB, we tested for genetic interactions between *CTF19* and several genes encoding either integral SPB proteins or proteins involved in SPB duplication. No synthetic lethal interactions were detected in any double mutants created between *ctf19*Δ*1* and *mps2-1*, *ndc1-1*, *cdc31-1*, *spc42-10*, *spc110-1*, *tub4-32*, or *tub4-34* (data not shown). In comparison to the unequivocal genetic interactions detected between *CTF19* and the genes encoding the CBF3 kinetochore components, we conclude that the function of Ctf19p lies at the kinetochore. We also tested for a genetic interaction between *CTF19* and *NDC80*, which encodes a spindle- and pole-associated protein. Interestingly, a conditional synthetic lethal effect was detected in *ndc80-1 ctf19*Δ*1* double mutants at 28°C. This genetic interaction is allele specific, as no conditional SL was detected in *ndc80-2 ctf19*Δ*1* double mutants. *NDC80* mutants display phenotypes very similar to a temperature-sensitive mutant of *NDC10*, which encodes a component of the CBF3 kinetochore complex ([@B59]). Although the phenotypes and immunofluorescent staining pattern of Ndc80p are consistent with localization to the kinetochore, no genetic interactions have been detected between *NDC80* and CBF3 kinetochore components ([@B59]). These authors have concluded that an indirect interaction may exist between Ndc80p and the kinetochore. It is quite possible that such an indirect interaction may occur through Ctf19p.

Discussion {#Discussion}
==========

We have identified and characterized the *CTF19* gene of *S. cerevisiae*, and show that it encodes a novel protein which is required for faithful chromosome transmission and efficient binding of centromeres to MTs, associates with a centromere DNA complex in vivo, and localizes to the SPB region. Previously, two uncharacterized mutations, *ctf19-58* and *ctf19-26*, were classified as putative kinetochore mutants by an in vivo centromere transcription readthrough assay ([@B7]). *ctf19* mutants were further implicated in kinetochore function by our SDL screen ([@B28]), in which overexpression of the *CTF13* reference gene, encoding an essential CBF3 kinetochore protein, resulted in lethality in the context of the *ctf19-58* and *ctf19-26* mutations. The phenotypes described here for *ctf19* mutants, including chromosome missegregation, increased sensitivity to benomyl, and a G2/M accumulation of logarithmically growing cells, are all consistent with a defect in kinetochore function.

Extensive genetic analysis revealed that *CTF19* exhibits strong genetic interactions with both kinetochore structural mutants and mitotic checkpoint mutants. Genetic interactions (SDL, SL, or both) were detected between the *ctf19* null mutation and mutant alleles of all four subunits of the CBF3 kinetochore complex, as well as with Mif2p, which has been shown to interact with *CEN* DNA in a CDEIII-specific manner ([@B38]). We also demonstrate that cells defective in, or overexpressing Ctf19p require a functional mitotic checkpoint pathway, as do cells defective in, or overexpressing Ctf13p. The extent and specificity of these interactions strongly implicates Ctf19p as playing a role in kinetochore structure or function.

Ctf19p Functions as Part of a Macromolecular Kinetochore Complex
----------------------------------------------------------------

Consistent with the numerous genetic interactions linking Ctf19p to the kinetochore, as well as the sedimentation data, we demonstrate that Ctf19p associates specifically with centromeric DNA in vivo through formaldehyde cross-linking followed by chromatin immunoprecipitation. Two known kinetochore proteins, Ndc10p and Cbf1p, as well as two implicated kinetochore proteins, Mif2p and Cse4p, have been shown to cross-link wild-type *CEN* DNA in vivo ([@B38]; [@B39]). Ndc10p and Mif2p both demonstrate a specific dependence on the integrity of CDEIII ([@B38]). A similar specificity of interaction between Ctf19p and CDEIII is described by Lechner and colleagues, who have independently identified Ctf19p as part of a complex of proteins that interacts with CBF3 ([@B52]). These data are consistent with genetic interactions reported here, which are also specific for CBF3 components.

The fact that Ctf19p is able to specifically cross-link *CEN* DNA does not differentiate between a direct and indirect association. Ctf19p is not a subunit of the CBF3 complex ([@B51]), and is not necessary for the gel mobility shift seen with the assembled kinetochore complex on a *CEN* DNA fragment (data not shown; Lechner, J., personal communication). Therefore we propose that Ctf19p interacts indirectly with *CEN* DNA, likely through interactions with the CBF3 complex, or perhaps through a larger macromolecular complex whose assembly is initiated by recruitment of CBF3 to CDEIII ([@B48]; [@B38]). Given the ability of Ctf19p to cross-link to *CEN* DNA, and the defect seen in the ability of *ctf19* mutants to bind centromeres of minichromosomes to MTs, Ctf19p would be a good candidate for a factor which interacts with CBF3 and is necessary to form active spindle MT-binding complexes. The fact that Ctf19p is able to associate with centromeric DNA in the presence of NZ suggests that MTs are not required for this association, and places Ctf19p at the kinetochore instead of on the spindle. Similar results were observed for Mif2p and Ndc10p. We are currently testing whether Ctf19p is required for attachment of reassembled kinetochore complexes in vitro to polymerized MTs.

Implications of a Kinetochore Protein with SPB Localization
-----------------------------------------------------------

The immunolocalization pattern of Ctf19p is consistent with kinetochore proteins, which is strongly supported by the genetic and biochemical data presented here. Other proteins which have been biochemically placed at the centromere, including Ndc10p, Mif2p, and Cse4p, show immunofluorescent staining patterns similar to Ctf19p. The SPB staining pattern observed in G1 cells and in late mitotic cells could be due to the effect of centromere clustering, a phenomenon seen in higher eukaryotes and demonstrated in yeast by fluorescent in situ hybridization ([@B18]). Studies on cell cycle dependent centromere positioning in *S*. *cerevisiae* reveal that in G1 cells, centromeres are loosely clustered around the SPB, similar to that reported for fission yeast and mammalian cells ([@B9]; [@B11]; [@B55]). In mitosis before anaphase (mid M), centromeres are centrally localized within the nucleus, away from the SPB, reminiscent of metaphase in larger eukaryotic cells. In anaphase and telophase cells, centromeres are clustered tightly and proximal to the SPBs. One caveat to interpreting the Ctf19p localization as consistent with it being a *CEN* binding protein is that, unlike Ndc10p ([@B16]) and Cse4p ([@B39]), Ctf19p does not display spindle staining, as may be expected for centromere associated proteins when kinetochores are forming bipolar attachments to the spindle MTs. The absence of spindle staining for Ctf19p may reflect limitations of the immunofluorescence assay, as other kinetochore proteins, including Ctf13p and Cep3p, have not been visualized in the cell by traditional immunofluorescent techniques, or it may reflect a unique role for Ctf19p in mitosis, perhaps functioning to tether kinetochores to the SPB. Given the prominent role of anaphase B in sister chromatid separation in budding yeast ([@B53]), Ctf19p may be important in stabilizing the link between kinetochores and each SPB during spindle pole separation.

The results of immunofluorescence with Ctf19-HAp in the presence of NZ suggest that at least some amount of Ctf19p localizes adjacent to the SPB, as opposed to Ctf19p residing solely at the kinetochores, because the positioning of kinetochores near the SPB is believed to be dependent on MTs. In the presence of NZ, it has been observed that centromeres are no longer clustered, but rather disperse throughout the nucleus ([@B18]), presumably because MTs are no longer present for the kinetochores to remain attached to the SPB. However, the procedures used to fix and process nuclei for in situ hybridization in yeast may be more disruptive than that used for immunofluorescence, and theoretically could contribute to an aberrant delocalization of centromeres after treatment with NZ. Although Ctf19-HAp does maintain a discrete localization in the presence of NZ, we did observe a few examples (∼7% of cells analyzed) in which more than two fluorescent signals were seen for Ctf19-HAp which did not correlate with a Tub4p signal. We reason that, because a small polymer of MTs may still be present at the face of the SPB even after NZ treatment ([@B35]; [@B22]), Ctf19p may be part of a complex that is peripheral to the SPB. The localization of this complex may be less stable in the presence of MT depolymerizing agents, accounting for the small population of cells that exhibit more than two Ctf19-HAp signals. [@B59] have identified several new spindle pole and spindle-associated proteins through analysis of purified spindle preparations with MALDI mass spectrometry. Ndc80p is of particular interest because it stains spindles as well as poles, and *ndc80-1* mutants display phenotypes similar to yeast kinetochore mutants, including chromosome missegregation and anaphase defects. In addition, Ndc80p is a potential homologue of human HEC protein, which localizes to the centromere. However, no genetic interactions were detected between *NDC80* and three of the CBF3 components tested. Ndc80p partially copurifies with the factors which bind kinetochores to MTs ([@B48]), but is absent from the final fraction ([@B59]). Since Ctf19p interacts with the centromere, both genetically and biochemically, and it genetically interacts with Ndc80p, we propose that Ctf19p provides a link between the mitotic spindle and the kinetochore in budding yeast.
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List of Yeast Strains Used in this Study

  Strains         Genotype                                                                                              Source
  ------------ -- -------------------------------------------------------------------------------------------------- -- ---------------------------
  YPH277          MATa *ura3-52 lys2-801 ade2-101 trp1Δ1 leu2Δ1 CFVII* (*RAD2d.* YPH277) *URA3 SUP11*                   F. Spencer and P. Hieter
  YPH500          MATα *ura3-52 lys2-801 ade2-101 his3Δ200 trp1Δ63 leu2Δ1*                                              P. Hieter
  YPH501          MATA/MATα *ura3-52/ura3-52 lys2-801/lys2-801 ade2-101/ade2-101 his3Δ200/his3Δ200*                     P. Hieter
                    *trp1Δ63/trp1Δ63 leu2Δ1/leu2Δ1*                                                                     
  YCTF58          MATα *ura3-52 lys2-801 ade2-101 his3Δ200 leu2Δ1* CFIII (*CEN3L.* YPH278) *URA3 SUP11 ctf19-58*        [@B28];
                                                                                                                         F. Spencer and P. Hieter
  YCTF26          MATα *ura3-52 lys2-801 ade2-101 his3Δ200 leu2Δ1* CFIII (*CEN3L.* YPH278) *URA3 SUP11 ctf19-26*        [@B28];
                                                                                                                         F. Spencer and P. Hieter
  YPH877          MATa *ura3-52 lys2-801 ade2-101 his3Δ200 trp1Δ1* CFVII (*RAD2d.* YPH877) *TRP1 SUP11*                 P. Hieter
  YPH982          MATa/MATα *ura3-52/ura3-52 lys2-801/lys2-801 ade2-101/ade2-101 his3Δ200/his3Δ200*                     P. Hieter
                    *trp1Δ63/trp1Δ63 leu2Δ1/leu2Δ1* CFIII (*CEN3L.* YPH982) *URA3 SUP11*                                
  YPH1314         MATα *ura3-52 lys2-801 ade2-101 his3Δ200 trp1Δ1 leu2Δ1 ctf19Δ1:HIS3*                                  This study
  YPH1315         MATa *ura3-52 lys2-801 ade2-101 his3Δ200 trp1Δ1 leu2Δ1 ctf19Δ1:HIS3*                                  This study
  YPH1125         MATa *ura3-52 lys2-801 ade2-101 his3Δ200 trp1Δ63 leu2Δ1* CFIII (*CEN3L.* YPH278) *URA3 SUP11*         This study
  YPH1316         MATα *ura3-52 lys2-801 ade2-101 his3Δ200 trp1Δ63 leu2Δ1 ctf19Δ1:TRP1*                                 This study
  YPH1317         MATa *ura3-52 lys2-801 ade2-101 his3Δ200 trp1Δ63 leu2Δ1 ctf19Δ1:TRP1*                                 This study
  YPH1318         MATα *ura3-52 lys2-801 ade2-101 his3Δ200 trp1Δ63 leu2Δ1 ctf19Δ1:TRP1*                                 This study
                   CFIII (*CEN3L*. YPH278) *URA3 SUP11*                                                                 
  YPH1319         MATa *ura3-52 lys2-801 ade2-101 his3Δ200 trp1Δ63 leu2Δ1 ctf19Δ1:TRP1*                                 This study
                   CFIII (*CEN3L.* YPH278) *URA3 SUP11*                                                                 
  YPH1320         MATa/MATα *ura3-52/ura3-52 lys2-801/lys2-801 ade2-101/ade2-101 his3Δ200/his3Δ200*                     This study
                    *trp1Δ63/trp1Δ63 leu2Δ1/leu2Δ1 ctf19Δ1:TRP1/ctf19Δ1:TRP1* CFIII (*CEN3L.* YPH278) *URA3 SUP11*      
  YPH1321         MATa/MATα *ura3-52/ura3-52 lys2-801/lys2-801 ade2-101/ade2-101 his3Δ200/his3Δ200*                     This study
                    *leu2Δ1/leu2Δ1 ctf19-58/ctf19-58* CFVII (*RAD2d.* YPH277) *URA3 SUP11*                              
  YPH1322         MATa/MATα *ura3-52/ura3-52 lys2-801/lys2-801 ade2-101/ade2-101 HIS3/his3Δ200*                         This study
                    *trp1Δ1/TRP1 leu2Δ1/leu2Δ1 ctf19-26/ctf19-26* CFVII (*RAD2d.* YPH277) *URA3 SUP11*                  
  YPH1329         MATa/MATα *ura3-52/ura3-52 lys2-801/lys2-801 ade2-101/ade2-101 his3Δ200/his3Δ200*                     This study
                    *trp1Δ1/trp1Δ1 leu2Δ1/leu2Δ1 ctf13-30/ctf13-30*                                                     
  YPH1330         MATa/MATα *ura3-52/ura3-52 lys2-801/lys2-801 ade2-101/ade2-101 his3Δ200/his3Δ200*                     This study
                    *trp1Δ1/trp1Δ1 leu2Δ1/leu2Δ1 ctf19Δ1:HIS3/ctf19Δ1:HIS3*                                             
  YPH1331         MATa/MATα *ura3-52/ura3-52 lys2-801/lys2-801 ade2-101/ade2-101 his3Δ200/his3Δ200*                     This study
                    *trp1Δ1/trp1Δ1 leu2Δ1/leu2Δ1 ctf13-30/ctf13-30 ctf19Δ1:HIS3/ctf19Δ1:HIS3*                           
  YPH1332         MATa/MATα *ura3-52/ura3-52 lys2-801/lys2-801 ade2-101/ade2-101 his3Δ200/his3Δ200*                     This study
                    *trp1Δ1/TRP1 leu2Δ1/leu2Δ1 ctf13-30/ctf13-30 ctf19Δ1:HIS3/ctf19Δ1:HIS3*                             
  YPH1327         MATa *ura3-52 lys2-801 ade2-101 his3Δ200 trp1Δ63 leu2Δ1 ctf19Δ1:TRP1 leu2Δ1::CTF19-3HA,HIS3*          This study
  YPH1328         MATa/MATα *ura3-52/ura3-52 lys2-801/lys2-801 ade2-101/ade2-101 his3Δ200/his3Δ200 trp1Δ63/*            This study
                    *trp1Δ63 leu2Δ1/leu2Δ1 ctf19Δ1:TRP1/ctf19Δ1:TRP1 leu2Δ1::CTF19-3HA/leu2Δ1::CTF19-3HA*               
  YPH1323         MATa *ura3-52 lys2-801 ade2-101 his3Δ200 trp1Δ63 leu2Δ1 ctf19Δ1:TRP1*                                 This study
                   CFIII (*CEN3L*. YPH278)*URA3 SUP11* \[YKH 65\] + pKH7(*CTF19-CEN-LEU2*; pRS315)                      
  YPH1324         MATa *ura3-52 lys2-801 ade2-101 his3Δ200 trp1Δ63 leu2Δ1 ctf19Δ1:TRP1*                                 This study
                   CFIII (*CEN3L*. YPH278)*URA3 SUP11* \[YKH 65\] + pKH32(*CTF19-3HA-CEN-LEU2*; pRS315)                 
  YPH1325         MATa *ura3-52 lys2-801 ade2-101 his3Δ200 trp1Δ63 leu2Δ1 ctf19Δ1/:TRP1*                                This study
                   CFIII (*CEN3L*. YPH278)*URA3 SUP11* \[YKH 65\] + pKH14(*CTF19-CEN-HIS3*; pRS 313)                    
  YPH1326         MATa *ura3-52 lys2-801 ade2-101 his3Δ200 trp1Δ63 leu2Δ1 ctf19Δ1:TRP1*                                 This study
                   CFIII (*CEN3L*. YPH278)*URA3 SUP11* \[YKH 65\] + pKH31(*CTF19-3HA-CEN-HIS3*; pRS313)                 
  YCTF30          MATa *ura3-52 lys2-801 ade2-101 his3Δ200 leu2Δ1* CFIII (*CEN3L*. YPH278) *URA3 SUP11 ctf13-30*        [@B50];
                                                                                                                          [@B28]
  YCTF42          MATα *ura3-52 lys2-801 ade2-101 his3Δ200 leu2Δ1* CFIII (*CEN3L.* YPH278) *URA3 SUP11 ndc10-42*        [@B50];
                                                                                                                          [@B28]
  YPH971          MATa *ura3 leu2 trp1 lys2 ndc10-1*                                                                    J. Kilmartin
  YPH1027         MATa *ura3-52 leu2-3,112 ndc10-2*                                                                     T. Huffaker
  YPH1234         MATα *ura3-52 lys2-801 ade2-101 his3Δ200 trp1Δ63 leu2Δ1 skp1-3::LEU2*                                 C. Connelly and P. Hieter
  YPH1235         MATα *ura3-52 lys2-801 ade2-101 his3Δ200 trp1Δ63 leu2Δ1 skp1-4::LEU2*                                 C. Connelly and P. Hieter
  YAS281          MATa *ura3 lys2 ade2 his3 trp1 leu2 cep3-1*                                                           [@B54]
  YAS282          MATa *ura3 lys2 ade2 his3 trp1 leu2 cep3-2*                                                           [@B54]
  YFP2            MATα *ura3-52 lys2-801 ade2-101 his3Δ200 leu2Δ1* CFIII (*CEN3L.* YPH278) *URA3 SUP11*                 F. Pangilinan and
                    *bub1Δ::LEU2*                                                                                        F. Spencer
  YFS822          MATa *ura3-52 lys2-801 ade2-101 his3Δ200 leu2Δ1* CFIII (*CEN3L.* YPH278) *URA3 SUP11*                 F. Pangilinan and
                    *bub2Δ::LEU2*                                                                                        F. Spencer
  YFP74           MATα *ura3-52 lys2-801 ade2-101 his3Δ200 leu2Δ1* CFIII (*CEN3L.* YPH278) *URA3 SUP11*                 F. Pangilinan and
                    *bub3Δ::LEU2*                                                                                        F. Spencer
  YPH1238         MATa *ura3-52 lys2-801 ade2-101 his3Δ200 trp1Δ63 leu2Δ1 mad2Δ::HIS3*                                  M. Mayer and P. Hieter
  YFS722          MATα *ura3-52 lys2-801 ade2-101 his3Δ200 trp1Δ1 leu2Δ1 rad9Δ::HIS3*                                   F. Spencer
  YPH311          MATa *ura3-52 ade2(ochre) his3Δ200 leu2-3,112 tub1-1*                                                 A. Hoyt and D. Botstein
  YPH312          MATα *ura3-52 ade2(ochre) tub2-104*                                                                   A. Hoyt and D. Botstein
  YNN421          MATa *ura3 ade2 his3 lys2 trp1 cbf1::TRP1*                                                            [@B5]
  SBD520-8c       MATα *ura3-52 leu2-3 ade2-101 trp1Δ* 901 his3-11,15 lys2-801 CEN3 *cse4-1::RSCL1-1H(HIS3)*            Stoler et al., 1995
  PMY1002-3A      MATα *ura3 leu2 trp1 mif2*-3                                                                          P. Meluh
  SMY6-4b         MATα *ura3-52 his3Δ200 leu2,3-112 mps2-1*                                                             Winey et al., 1991
  HC10-42D        MATα *ura3-52 ade2 ndc1-1*                                                                            Winey et al., 1993
  ELW65-9d        MATa *ura3-52 trp1-1 cdc31-2 + pCDC31;URA3*                                                           M. Winey
  TSY498          MATα *ura3-52 lys2-801 his3Δ200 leu2-3,112 tub4-32*                                                   [@B35]
  TSY502          MATa *ra3-52 lys2-801 his3Δ200 leu2-3,112 tub4-34*                                                    [@B35]
  Yspc42-10       MATa *ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3 spc42Δ::LEU2 spc42-10,TRP1::trp1-1*           Donaldson and
                                                                                                                         Kilmartin, 1996
  Yspc110-1       MATa *ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3 spc110Δ::LEU2 spc110-1,TRP1::trp1-1*          J.V. Kilmartin
  Yndc80-1        MATa *ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3 ndc80-1*                                      [@B59]
  Yndc80-2        MATa *ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3 ndc80-2*                                      [@B59]
                                                                                                                        

![CTF19 genomic clone, overexpression construct, epitope tag fusion construct, and schematic of protein. (a) A simple restriction map of the 2-kb genomic clone. (b) Overexpression and E1 epitope-tagged constructs with *CTF19* under control of a *GAL1* promoter. (c) NH~2~-terminal 3XHA epitope-tagged Ctf19p fusion protein. Three HA tags were inserted in tandem at a StuI site which was generated by PCR based site-directed mutagenesis directly after the ATG. (d) Schematic of Ctf19p, showing putative leucine zipper.](JCB9811090.f1){#F1}

![Phenotypes of *ctf19* mutants. (a) Benomyl sensitivity; serial dilutions of yeast cells (YPH278, YCTF58, YPH1125, YPH1319, YPH311, and YPH312) were spotted onto YPD plates containing the indicated concentrations of benomyl, and were photographed after 4 d at 25°C. (b) Flow cytometry profiles for homozygous diploid cultures of wild-type *CTF19* (YPH501) and *ctf19*Δ*1* (YPH1330) strains at 25°C.](JCB9811090.f2){#F2}

###### 

Rates of Chromosome Missegregation Events in ctf19 Mutants

  Genotype[\*](#TFII-150){ref-type="table-fn"}            1:0 Events[‡](#TFII-152){ref-type="table-fn"}      2:0 Events[§](#TFII-153){ref-type="table-fn"}      Total \# colonies
  ---------------------------------------------------- -- ----------------------------------------------- -- ----------------------------------------------- -- -------------------
  [*ctf19Δ::TRP1*]{.ul}                                                                                                                                         
  *ctf19Δ::TRP1*                                          2.8                                                1.8                                                 2,737
  [*ctf19*-*58*]{.ul}                                                                                                                                           
  *ctf19*-*58*                                            2.3                                                0.5                                                 2,533
  [*ctf19*-*26*]{.ul}                                                                                                                                           
  *ctf19*-*26*                                            1.1                                                0.4                                                 3,180
  *[CTF19]{.ul}* [‖](#TFII-155){ref-type="table-fn"}                                                                                                            
  *CTF19*                                                 0.03                                                 0.03                                             29,046

Mutants of the above genotypes were plated to single colonies and visual sectoring phenotypes were scored. Colonies scored as half-sectored were ≥50% red ([@B27]; [@B14]).  

 Strains used were YKH67, YKH588, YKH590, and YPH279 

.  

 1:0 events (chromosome loss) were scored as colonies that are half red, half pink. Rates are shown as events per 100 cells.  

 2:0 events (nondisjunction) were scored as above for half red, half white colonies. Rates are shown as events per 100 cells.  

^∥^ Rates for wild-type YPH279 are as reported by [@B14].  

###### 

Dosage Studies with Kinetochore Mutants

  Mutant strain                                          Gene overexpressed[\*](#TFIII-150){ref-type="table-fn"}      
  --------------------------------------------------- -- --------------------------------------------------------- -- ----------------------------------------------
                                                         *GAL-CTF13*                                                  *GAL-CTF19*
  *ctf13-30*                                             \+                                                           \+
  *ndc10-42*                                             SDL                                                          SDL
  *ndc10-1*                                              SDL[‡](#TFIII-152){ref-type="table-fn"}                           SDL[‡](#TFIII-152){ref-type="table-fn"}
  *ndc10-2*                                              \+                                                           \+
  *skp1-3*                                               \+                                                           \+
  *skp1-4*                                               DS                                                           \+
  *cep3-1*                                               SDL                                                          \+
  *cep3-2*                                               SDL                                                          \+
  *ctf19Δ1::TRP1*                                        SDL                                                          \+
  *ctf19*-*58*                                           SDL                                                          \+
  *ctf19*-*26* [‡](#TFIII-152){ref-type="table-fn"}      SDL                                                          \+

+, normal growth; SDL, synthetic dosage lethality; DS, dosage suppression (i.e., rescue of viability at the nonpermissive temperature).  

 Phenotypes are at 25°C, unless otherwise indicated.  

 Temperature ≥30°C.  

###### 

Synthetic Lethal Interactions between ctf19Δ1 and Kinetochore Mutants

  Double mutant genotype       Phenotype                                   4-Spore tetrads      3-Spore tetrads      2-Spore tetrads      1-Spore tetrads      Total tetrads      Viable spores[\*](#TFIV-150){ref-type="table-fn"}
  ------------------------- -- ---------------------------------------- -- ----------------- -- ----------------- -- ----------------- -- ----------------- -- --------------- -- ---------------------------------------------------
                                                                                                                                                               *\#*               *%*
  *ctf19Δ::HIS3 ctf13-30*      CSL[‡](#TFIV-152){ref-type="table-fn"}      19                    3                   0                    0                    22                 97
  *ctf19Δ::HIS3 ndc10-42*      SL                                           4                   15                   9                    2                    30                 68
  *ctf19Δ::TRP1 ndc10-1*       Viable                                      21                    4                   0                    0                    25                 96
  *ctf19Δ::TRP1 cep3-1*        SL                                           7                   15                   5                    2                    29                 72
  *ctf19Δ::TRP1 cep3-2*        SL                                           5                   11                   4                    0                    20                 76
  *ctf19Δ::TRP1 skp1-3*        Viable                                      14                    2                   0                    0                    16                 97
  *ctf19Δ::TRP1 skp1-4*        CSL[§](#TFIV-153){ref-type="table-fn"}      15                    2                   1                    0                    18                 94
  *ctf19Δ::TRP1 sgt1-3*        CSL[‖](#TFIV-155){ref-type="table-fn"}      18                    2                   8                    2                    30                 80
  *ctf19Δ::TRP1 sgt1-5*        Viable                                      24                    0                   2                    1                    27                 94
  *ctf19Δ::TRP1 mif2-3*        SL                                           5                   20                   4                    1                    30                 74

 Numbers presented are for 25°C. Percent viable spores = number of viable spores from a given mating/total number of possible spores.  

  *ctf19Δ::HIS3 ctf13-30* double mutant spores were inviable at 30°C. The nonpermissive temperature of *ctf13-30* is 36°C.  

  *ctf19Δ::TRP1 skp1-4* double mutant spores were inviable at 28°C. The nonpermissive temperature of *skp1-4* is 37°C.  

  *ctf19Δ::TRP1 sgt1-3* double mutant spores were inviable at 30°C. The nonpermissive temperature for *sgt1-3* is 37°C. SL, synthetic lethality; CSL, conditional synthetic lethality, at temperatures indicated.  

###### 

Synthetic Lethal Interactions between ctf19Δ and Mitotic Checkpoint Mutants

  Double mutant genotype                                          Phenotype                                 4-Spore tetrads      3-Spore tetrads      2-Spore tetrads      1-Spore tetrads      Total tetrads      Viable spores[\*](#TFV-150){ref-type="table-fn"}
  ------------------------------------------------------------ -- -------------------------------------- -- ----------------- -- ----------------- -- ----------------- -- ----------------- -- --------------- -- --------------------------------------------------
                                                                                                                                                                                                *\#*               *%*
  *ctf19Δ::HIS3 bub1Δ::LEU2*                                      SL                                         2                    6                    8                   4                    20                 58
  *ctf19Δ::HIS3 bub2Δ::LEU2*                                      Viable                                    12                    3                    3                   1                    19                 84
  *ctf19Δ::HIS3 bub3Δ::*                                          SL[‡](#TFV-152){ref-type="table-fn"}      16                    8                    6                   1                    31                 81
    *LEU2* + p*BUB3-URA3* [‡](#TFV-152){ref-type="table-fn"}                                                                                                                                                       
  *ctf19Δ::TRP1 mad2Δ::HIS3*                                      SL                                         6                   10                   12                   0                    28                 70
  *ctf19Δ::TRP1 rad9Δ::HIS3*                                      Viable                                    26                    1                    3                   0                    30                 94

 Numbers presented are for 25°C.  

 Analysis of spores from this diploid required the inclusion of a plasmid (p*BUB3-URA3*) before sporulation to achieve sufficient sporulation efficiency and acceptable viability of spore products. Double mutant spores containing p*BUD3-URA3* were not viable on FOA plates, thus confirming synthetic lethality between *bub3* and *ctf19.*  

![*ctf19* mutants exhibit reduced MT binding to minichromosomes. Cleared lysates were prepared from wild-type *CTF19* (solid line with squares), *ctf19-26* (dotted line with triangles), and *ctf19-58* (dashed line with circles) cells containing minichromosomes. Increasing amounts of taxol stabilized bovine MTs were added to the lysates for 15 min at 23°C. MTs were pelleted, and the percentage of minichromosomes that cosedimented with MTs was determined (see [@B24]).](JCB9811090.f3){#F3}

![Coimmunoprecipitation of *CEN* DNA with Ctf19p. (a) Formaldehyde cross-linked chromatin (2 h fixation) prepared from a wild-type *CTF19* untagged strain (YPH500) and a *CTF19-HA* epitope-tagged strain (YPH1327) were immunoprecipitated with anti-HA antibody, anti-Mif2p antiserum, or mock-treated (No Ab). Experimental reactions were prepared in duplicate. Total input material (3 μl chromatin solution, at a 1:5 dilution) and coimmunoprecipitated DNA (equal to ∼30 μl chromatin solution) were analyzed by PCR with primers specific for *CEN3* (244 bp), *CEN16* (345 bp), or two noncentromeric loci on chromosome III, *HMR1* (314 bp) and *PGK1* (288 bp). (b) The same wild-type untagged and *CTF19-HA* tagged strains used in a were treated with NZ, then fixed in formaldehyde, processed, and immunoprecipitated as above. Shown is the *CEN3* PCR product. A similar result was seen with primers for *CEN16*. As in a, no PCR product was seen in the α-mif2 or α-HA immunoprecipitate for the noncentromeric loci tested (not shown).](JCB9811090.f4){#F4}

![Ctf19p localizes to the SPB region. Immunofluorescence with a *CTF19-3HA* epitope-tagged strain (YPH1384; a) and an untagged control strain (YPH1323; b). Shown in the first panel of a are two early anaphase cells. The second panel exhibits an anaphase cell, an interphase cell with a single SPB, and a cell with a duplicated SPB. (b) Two representative untagged control cells, one in early anaphase, and one in telophase. No signals were seen with the anti-HA antibody in any untagged control cells analyzed. Ctf19p was detected with anti-HA antibody followed by FITC conjugated goat anti--mouse secondary antibody. Spindle MTs were detected with anti--α-tubulin antibody followed by rhodamine conjugated goat anti--rat secondary antibody. Total DNA was stained with DAPI.](JCB9811090.f5){#F5}

![The localization of Ctf19-HAp is similar to Tub4p, a known SPB component. (a) A strain containing *CTF19-3HA* (integrated into the genome, YPH1327) and (b) a wild-type control strain (YPH500) were fixed and stained with anti-HA antibody to detect Ctf19-HAp, anti-Tub4p, and the DNA stain DAPI. Bar, 5 μm. (c) Cells were treated with 20 μg/ml NZ for 2 h at 25°C to depolymerize the MTs. No MT staining was detected after NZ treatment (not shown). Ctf19-HAp staining remains at the SPB, as does the SPB marker Tub4p. Note that a few cells in this field display an additional Ctf19-HAp signal which does not correspond to a Tub4p signal. The inset clearly demonstrates this phenomenon, which is seen in ∼7% of cells analyzed. (d) A merged image, with Ctf19-HAp stained green (FITC) and Tub4p stained red (Cy3). Note that complete colocalization, observed as yellow spots, is seen in cells with a single SPB or with elongated spindles as in late anaphase or telophase (arrows), whereas in cells with short spindles, the green Ctf19-HAp staining is seen adjacent (interior) to the red Tub4p staining (arrowheads).](JCB9811090.f6){#F6}
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